Medical Oncologist
EGFR-mutant lung cancer
Gefitinib in Early-Stage vs — Advanced Lung Cancer: Different Goals
Gefitinib is prescribed in two very different situations: after surgery for early-stage lung cancer, and for lung cancer that has spread. The goals are not the same, and knowing which one applies to you changes what you should expect from treatment.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed August 2026
- Two different goals — After surgery, gefitinib aims to keep the cancer from returning. In advanced disease, it aims to slow its spread.
- Duration differs — Adjuvant gefitinib is given for a set period. Advanced disease treatment continues until the medication stops working or causes problems.
- The tablet looks the same — Gefitinib looks identical in both settings. The difference is in why you are taking it, not what you are taking.
- EGFR testing is needed in both — Your tumour must have an EGFR mutation for gefitinib to work, whether your disease is early-stage or advanced.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Gefitinib serves two different purposes in lung cancer. After surgery for early-stage disease, it is given to reduce the risk of the cancer returning — this is adjuvant therapy. In advanced lung cancer, it aims to slow the spread of the disease and keep it under control for as long as possible. The goals are not the same.
Why am I taking gefitinib if my cancer was removed by surgery?
When a lung tumour is removed completely by surgery, microscopic cancer cells may remain in the body even when imaging looks clear. Adjuvant therapy is treatment given after surgery to reach those cells before they can grow into a new tumour.
NCCN and ESMO guidelines recommend adjuvant EGFR TKI therapy for people with resected early-stage lung cancer where an EGFR mutation is confirmed. Gefitinib is one of the recommended options in this setting. You take it as a once-daily tablet for a set period agreed with your oncologist.
The aim is for you to finish the course and remain disease-free afterwards. You are not taking it because cancer is present now — you are taking it to protect the outcome of your surgery.
What is gefitinib doing when lung cancer has already spread?
When lung cancer has spread to lymph nodes, the other lung, or other organs, surgery cannot remove all the disease. The goal in this setting is control — slowing the growth and spread of the cancer for as long as possible.
For advanced non-small cell lung cancer with a confirmed EGFR mutation, gefitinib is a first-line treatment recommended by NCCN, ASCO and ESMO. You take it as a once-daily tablet and continue for as long as it is working.
When the cancer eventually finds a way to grow despite the tablet — a process called resistance — your oncologist will assess what comes next. There is no planned end to the course; the treatment continues until it stops being effective.
Does being on gefitinib tell me how serious my cancer is?
It does not. The same tablet is used in both settings because it works by the same mechanism — blocking the signal from a mutated EGFR gene that drives the cancer to grow. The biology is the same; what differs is where the disease is and what the treatment is intended to achieve.
If you are taking gefitinib after surgery, that means your cancer was caught and removed. You are taking a tablet to protect that outcome. If someone else you know is on the same tablet for spread disease, they are in a different situation — even if the prescription looks identical.
If you are unsure which situation applies to you, ask your oncologist directly: 'Is this treatment meant to prevent the cancer coming back, or to treat cancer that is still present?' That is a question you are entitled to a clear answer to.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
You do not have to work this out alone
A 45-minute consultation with a specialist who treats this every week.
What do these words in my treatment plan mean?
- Adjuvant therapy
- Treatment given after a curative procedure such as surgery, intended to reduce the risk of the cancer returning. You take it when there is no visible cancer remaining.
- EGFR mutation
- A change in the EGFR gene that drives some lung cancers to grow. Gefitinib works by blocking this signal. Your tumour must be tested for this mutation before gefitinib is prescribed.
- Resection
- Surgical removal of the tumour. A complete resection means the surgeon removed all visible disease. Adjuvant therapy is given after a successful resection.
- Advanced lung cancer
- Lung cancer that has spread beyond the original tumour site — to nearby structures, lymph nodes, or other organs. Also described as metastatic or stage IV disease.
- Resistance
- The point at which a cancer finds a way to grow despite targeted therapy. When this happens, your oncologist will recommend the next step based on what has changed in the cancer.
- Disease-free survival
- How long a person remains without detectable cancer after treatment. This is the key measure in adjuvant therapy — it is different from the measures used in advanced disease.
What should you confirm before starting gefitinib?
- Ask your oncologist whether your treatment is adjuvant (after surgery) or for active advanced disease — these have different goals.
- Confirm your tumour has been tested for an EGFR mutation and the result is positive.
- Find out how long your treatment is planned to last and what will determine when it ends.
- Ask what your next scan will be looking for — signs of recurrence, or response to ongoing treatment.
- Know which symptoms to report immediately rather than waiting for your next scheduled appointment.
- Tell your oncologist everything you are taking — including supplements and herbal medicines — before you start.
Did you know?
EGFR mutations are found in a higher proportion of never-smokers and people of South or East Asian origin with lung adenocarcinoma than in other groups.
This is one of the reasons EGFR-targeted therapy is particularly relevant to patients in India, and why EGFR testing matters even when a patient's smoking history might have suggested a different cancer profile.
Source: ESMO Clinical Practice Guidelines: Non-small-cell lung cancer
Explore 75 more Lung Cancer Targeted Medicines topics
Drug Deep Dive: Gefitinib (Iressa)
- Diarrhoea on Gefitinib: Home Management and Warning Signs
- Diet and Nutrition While on Gefitinib
- Fertility, Pregnancy and Contraception on Gefitinib
- Gefitinib (Iressa, Geftinat, Geftib): The Complete Patient Guide
- Gefitinib Myths: 'It's Only for Poor Patients' and Other Half-Truths
- Gefitinib Plus Chemotherapy: Does Adding Chemo Actually Help?
- Gefitinib Price in India: Brand, Generic and Monthly Cost
- Gefitinib Rash: Why It Appears in Week Two and How to Treat It
- Gefitinib Side Effects: The Complete List and Timeline
- Gefitinib Success Rate and Survival: An Honest Look at the Numbers
- Gefitinib and Antacids: The Interaction That Silently Reduces Absorption
- Gefitinib in Early-Stage vs Advanced Lung Cancer: Different Goals
- Gefitinib in Elderly Patients and Those With Other Illnesses
- Gefitinib vs Osimertinib: Making the Decision When Cost Matters
- How Does Gefitinib Work? The First-Generation EGFR Inhibitor Explained
- How Long Does Gefitinib Take to Work?
- How Long Will You Stay on Gefitinib?
- Raised Liver Enzymes on Gefitinib: What Your LFT Report Means
- T790M Testing After Gefitinib Stops Working: The Next Step Explained
- Taking Gefitinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Gefitinib
- When Gefitinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Gefitinib? EGFR-Mutant Lung Cancer
- Will Insurance or a Government Scheme Pay for Gefitinib?
- Work, Travel and Daily Life on Gefitinib
Drug Deep Dive: Alectinib (Alecensa)
- Alectinib (Alecensa, Alectinib): The Complete Patient Guide
- Alectinib After Surgery for Early-Stage ALK-Positive Lung Cancer
- Alectinib Myths: Is ALK-Positive Cancer 'Curable'?
- Alectinib Price in India: Brand, Generic and Monthly Cost
- Alectinib Side Effects: The Complete List and Timeline
- Alectinib Success Rate and Survival: An Honest Look at the Numbers
- Alectinib and Brain Metastases: How It Protects the Brain
- Alectinib in Elderly Patients and Those With Other Illnesses
- Alectinib vs Crizotinib vs Lorlatinib: Choosing an ALK Inhibitor
- Diet and Nutrition While on Alectinib
- Do You Need Chemotherapy Alongside Alectinib?
- Drug, Food and Supplement Interactions With Alectinib
- Fertility, Pregnancy and Contraception on Alectinib
- How Does Alectinib Work? The Second-Generation ALK Inhibitor Explained
- How Long Does Alectinib Take to Work?
- How Long Will You Stay on Alectinib?
- Muscle Pain and High CPK on Alectinib: When to Worry
- Severe Sun Sensitivity on Alectinib: Preventing Serious Burns
- Taking Alectinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Alectinib
- Weight Gain, Constipation and a Slow Pulse on Alectinib
- When Alectinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Alectinib? ALK-Positive Lung Cancer
- Will Insurance or a Government Scheme Pay for Alectinib?
- Work, Travel and Daily Life on Alectinib
Drug Deep Dive: Osimertinib (Tagrisso)
- Adjuvant Osimertinib After Lung Cancer Surgery: Three Years of Tablets
- Breathlessness or New Cough on Osimertinib: Recognising Lung Injury (ILD)
- Diet and Nutrition While on Osimertinib
- Drug, Food and Supplement Interactions With Osimertinib
- Fertility, Pregnancy and Contraception on Osimertinib
- Heart Rhythm and Ejection Fraction Changes on Osimertinib
- How Does Osimertinib Work? The Third-Generation EGFR Inhibitor Explained
- How Long Does Osimertinib Take to Work?
- How Long Will You Stay on Osimertinib?
- Osimertinib (Tagrisso): The Complete Patient Guide
- Osimertinib Myths: Clear Scans, Stopping Early and Generic Quality
- Osimertinib Price in India: Brand, Generic and Monthly Cost
- Osimertinib Side Effects: The Complete List and Timeline
- Osimertinib Success Rate and Survival: An Honest Look at the Numbers
- Osimertinib With Chemotherapy: Who Actually Benefits From the Combination?
- Osimertinib and Brain Metastases: Why It Works Inside the Brain
- Osimertinib in Elderly Patients and Those With Other Illnesses
- Osimertinib vs Gefitinib and Erlotinib: Is the Costlier Drug Worth It?
- Rash, Dry Skin and Nail Problems on Osimertinib
- Taking Osimertinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Osimertinib
- When Osimertinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Osimertinib? EGFR-Mutant Lung Cancer
- Will Insurance or a Government Scheme Pay for Osimertinib?
- Work, Travel and Daily Life on Osimertinib
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
If my cancer was surgically removed, why do I still need to take a tablet every day?
After surgery removes a lung tumour, microscopic cancer cells can remain in the body even when imaging looks clear. Adjuvant gefitinib is intended to address those cells before they can grow into a new tumour. You are not taking it because cancer is present now — you are taking it to reduce the risk that it returns. This is the same principle as adjuvant chemotherapy, but specific to your EGFR mutation and delivered as a daily tablet rather than an infusion.
My relative has advanced lung cancer and is also on gefitinib. Does that mean our situations are the same?
Not necessarily. Gefitinib is used in two different settings — after surgery to reduce recurrence risk, and for cancer that has already spread. The tablet and the mutation are the same in both situations; the goal and the planned duration of treatment are different. If your relative has advanced disease and you are taking it after surgery, you are genuinely in different situations. Ask your oncologist to explain your own stage and treatment intent clearly if there is any uncertainty.
How long will I need to take gefitinib?
That depends on which situation you are in. Adjuvant gefitinib, given after surgery for early-stage disease, is taken for a set period determined by your oncologist based on current NCCN and ESMO guidance — there is a planned end point. Gefitinib for advanced disease is taken for as long as it continues to control the cancer and you can tolerate it — there is no fixed end point. Knowing which applies to you is one of the most important things to confirm with your team before you start.
What is my scan looking for while I am on gefitinib?
The answer differs depending on why you are taking it. After surgery for early-stage disease, scans are looking for any sign that the cancer has returned. In advanced disease, scans are measuring how well the drug is controlling the cancer — whether it has shrunk, stayed stable, or grown. If you are ever unsure what a scan result means for your situation, ask your oncologist to explain it in terms of which of those questions it was trying to answer.
What happens when gefitinib stops working?
In the adjuvant setting, gefitinib stops because the planned course of treatment is complete — not because the cancer has returned. If the cancer does return after that, your oncologist will reassess based on where and how it has come back. In advanced disease, gefitinib stops working when the cancer develops resistance, which eventually occurs in most people on targeted therapy. When that happens, your oncologist will recommend the next treatment based on what has changed in the cancer and what options are available.
Is gefitinib available at CION?
Yes. Gefitinib is given as day care at CION centres across Telangana and Andhra Pradesh. EGFR biomarker testing required before treatment is coordinated with partner laboratories. PET-CT scans for staging or response assessment are coordinated with partner imaging centres. CION does not provide CAR-T or cell therapy; if that is being considered for you, you would be referred to a centre that offers it.